Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Fungus – except allergen – or component thereof or substance...
Patent
1974-10-25
1976-06-29
Moyer, Donald B.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Fungus, except allergen, or component thereof or substance...
A61K 3140
Patent
active
039669572
ABSTRACT:
A method is disclosed for controlling emesis utilizing N-(1-substituted-3-pyrrolidinyl)benzamides and thiobenzamides of the formula: ##SPC1##
Wherein R is cycloalkyl, phenyl and phenyllower-alkyl; R.sup.1 is hydrogen, lower alkyl of 1 to 8 carbon atoms and phenyl; R.sup.2 is halogen, lower-alkyl, lower-alkoxy, amino, nitro, monoalkylamino, dialkylamino, mercaptomethyl, acetamido, sulfamoyl, cyano, hydroxy, benzyloxy, and trifluoromethyl; X is oxygen and sulfur; n is an integer from zero to three inclusive and pharmaceutically acceptable acid addition salts thereof. The benzamide compounds wherein R is cyclohexyl and R.sup.1 is lower-alkyl are particularly effective as antiemetics and have minimal side effects.
REFERENCES:
patent: 3342826 (1967-09-01), Miller et al.
patent: 3415934 (1968-12-01), Thominet
patent: 3577440 (1971-05-01), Lunsford et al.
Cale, Jr. Albert Duncan
Leonard Charles Arthur
A. H. Robins Company Incorporated
Moyer Donald B.
LandOfFree
Method for controlling emesis with N-(1-substituted-3-pyrrolidin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for controlling emesis with N-(1-substituted-3-pyrrolidin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for controlling emesis with N-(1-substituted-3-pyrrolidin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1278764